tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co (JP:4967)
:4967
Japanese Market

Kobayashi Pharmaceutical Co (4967) Income Statement

Compare
0 Followers

Kobayashi Pharmaceutical Co Income Statement

Last quarter (Q2 2025), Kobayashi Pharmaceutical Co's total revenue was ¥36.41B, a decrease of -0.65% from the same quarter last year. In Q2, Kobayashi Pharmaceutical Co's net income was ¥1.54B. See Kobayashi Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 165.60B¥ 173.46B¥ 166.26B¥ 155.25B¥ 150.51B
Gross Profit
¥ 87.60B¥ 96.38B¥ 92.33B¥ 88.77B¥ 85.27B
Operating Expenses
¥ 62.74B¥ 70.60B¥ 65.66B¥ 62.70B¥ 59.32B
Depreciation and Amortization
¥ 8.02B¥ 6.06B¥ 5.36B¥ 4.83B¥ 4.11B
EBITDA
¥ 21.96B¥ 33.65B¥ 33.33B¥ 32.49B¥ 30.76B
Operating Income
¥ 24.86B¥ 25.78B¥ 26.67B¥ 26.07B¥ 25.94B
Other Income/Expenses
¥ -10.95B¥ 1.78B¥ 1.28B¥ 1.57B¥ 692.00M
Pretax Income
¥ 13.91B¥ 27.56B¥ 27.95B¥ 27.64B¥ 26.64B
Net Income
¥ 10.07B¥ 20.34B¥ 20.02B¥ 19.71B¥ 19.20B
Per Share Metrics
Basic EPS
¥ 135.42¥ 268.16¥ 259.61¥ 252.35¥ 245.70
Diluted EPS
¥ 135.42¥ 268.16¥ 259.58¥ 252.35¥ 245.70
Weighted Average Shares Outstanding
74.34M 75.84M 77.12M 78.13M 78.16M
Weighted Average Shares Outstanding (Diluted)
74.34M 75.84M 77.13M 78.13M 78.16M
Currency in JPY

Kobayashi Pharmaceutical Co Earnings and Revenue History